Research Overview of IGF-1 L-R3
IGF-1 L-R3 is a synthetic analogue of insulin-like growth factor-1 featuring amino acid substitutions at positions 3 and 83, creating a modified peptide sequence with extended biological activity. This research compound exhibits reduced binding affinity to IGF-binding proteins compared to native IGF-1, enabling more direct cellular interaction in laboratory studies. The L-R3 modification involves substitution of glutamic acid for arginine at position 3 and replacement of the original sequence with a 13-amino acid extension, resulting in enhanced stability and prolonged activity in research environments.
Researchers at Stroid UK Shop can examine IGF-1 L-R3’s molecular mechanisms through various in-vitro protocols. The compound demonstrates significant binding affinity to IGF-1 receptors while showing reduced interaction with IGF-binding proteins, making it valuable for studies investigating direct receptor-mediated cellular responses.
Laboratory Research Applications
Scientists investigate IGF-1 L-R3 in cellular proliferation studies, examining its effects on mitogenic signalling pathways and protein synthesis mechanisms. Research applications include evaluating glucose uptake enhancement in muscle cell cultures, investigating anabolic signalling cascades, and analysing cellular differentiation processes. The compound serves as a valuable tool for studying growth factor biology, metabolic regulation, and tissue development mechanisms in controlled laboratory environments.
Comparative studies often examine IGF-1 L-R3 alongside other growth factors and peptides from our extensive peptides collection. Researchers may also incorporate SARMs or compounds from our IGF-1 peptide category for comprehensive growth factor research protocols.
Product Specifications
| Parameter | Specification |
|---|---|
| Molecular Weight | Approximately 9.1 kDa |
| Sequence Length | 83 amino acids |
| Purity | ≥98% (HPLC verified) |
| Format | Lyophilised powder |
| Storage | -20°C (long-term), 2-8°C (reconstituted) |
| Solubility | Water, buffered solutions |
| CAS Number | Verify with supplier |
Research Compliance Statement
This IGF-1 L-R3 product is manufactured by Odin Pharmaceuticals exclusively for in-vitro laboratory research purposes. The compound is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must ensure proper laboratory protocols, safety measures, and regulatory compliance when handling this research material. All studies should be conducted by qualified personnel in appropriate research facilities with suitable safety equipment and waste disposal procedures.
